Physician profile
Robert D Martin
NPI 1497922793
$8,369.97
in general payments reported to CMS, 2019-2025
9 companies · $158 in 2025
The $158 reported for 2025 was less than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,180 · 2020: $192 · 2021: $2,511 · 2022: $1,351 · 2023: $922 · 2024: $55.70 · 2025: $158.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $746 · Food and Beverage: $390.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $745.99 |
| Food and Beverage | $390.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Midsouth Orthopedics INC. | $6,855.04 | 2019-2025 | |
| Paragon 28, INC. | $745.99 | 2023 | Portfolio |
| Arthrex, INC. | $223.10 | 2020-2023 | Distal Extremities Implants Foot & Ankle Ttc Nail |
| Wright Medical Technology, INC. | $164.60 | 2019 | |
| Stryker Corporation | $135.21 | 2025 | Infinity Adaptis, T2 Alpha, Gamma |
| Depuy Synthes Sales INC. | $119.45 | 2019 | |
| Exactech, INC. | $63.34 | 2022 | |
| In2bones USA, LLC | $32.94 | 2020 | |
| International Life Sciences | $30.30 | 2024 | Flexband |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.